Pasadena, CA, United States of America

David A Tirrell

USPTO Granted Patents = 21 

 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 465(Granted Patents)


Location History:

  • Sunderland, MA (US) (2000)
  • Pasadena, CA (US) (2003 - 2020)

Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Innovations and Contributions of David A. Tirrell in Biotechnology

Introduction

David A. Tirrell, based in Pasadena, CA, is a prominent inventor in the field of biotechnology with a remarkable portfolio of 21 patents. His work primarily focuses on novel insulin derivatives and modified therapeutic molecules, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Among his latest innovations, Tirrell has developed patents related to non-canonical insulins and their uses. One particular patent describes an insulin derivative that includes a cyclic amino acid at positions B28 or B29, excluding L-proline. This invention encompasses methods for producing such derivatives, as well as pharmaceutical compositions for administering these innovative treatments for various diseases. Another noteworthy patent introduces amino acid substituted molecules, providing comprehensive methods for identifying, modifying, and producing modified target molecules, including therapeutic agents. This patent underscores the potential of using non-natural amino acids for molecular modification, enhancing the efficacy of therapeutic treatments.

Career Highlights

David A. Tirrell has had a distinguished career, with significant tenures at prestigious institutions such as the California Institute of Technology and the University of Washington. His academic and research roles have contributed profoundly to the field of biotechnology, where he has been instrumental in transforming theoretical concepts into practical applications through his inventions.

Collaborations

Throughout his career, Tirrell has collaborated with notable coworkers, including Allan Sachs Hoffman and Patrick S. Stayton. These partnerships have fostered a collaborative environment that encourages innovation and the development of new biotechnological solutions, amplifying the impact of his work in the scientific community.

Conclusion

David A. Tirrell's extensive contributions to biotechnology, underscored by his 21 patents, reflect his dedication to improving health outcomes through innovative inventions. His ongoing work in creating novel insulin derivatives and modified therapeutic molecules continues to inspire advancements within the field, establishing him as a leading inventor in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…